help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Garcia Del Rio, C.
Right arrow Articles by Morton, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Garcia Del Rio, C.
Right arrow Articles by Morton, J. J.

Endocrinology, Vol 108, 406-412, Copyright © 1981 by Endocrine Society


ARTICLES

des-Asp-angiotensin I: its identification in rat blood and confirmation as a substrate for converting enzyme

C Garcia Del Rio, WS Smellie and JJ Morton

The observation that angiotensin III is present in the circulation of the rat in amounts similar to those of angiotensin II has led to the notion that it may, in part, be formed by the action of converting enzyme on des-Asp-angiotensin I without the prior formation of angiotensin II. This possibility was studied in conscious rats using a combination of RIA and chromatographic techniques which allowed the separate measurement of angiotensin I, des-Asp-angiotensin I, angiotensin II, and angiotensin III in rat blood. Infusion of des-Asp1- [Ile5]angiotensin I at 50, 150, and 450 ng/kg . min resulted in a progressive increase in the plasma concentration of angiotensin III up to 279 +/- 50 (SD) pg/ml compared to 9 +/- 9 (SD) pg/ml after dextrose infusion. Regardless of the infusion of des Asp-[Ile5]angiotensin I, plasma angiotensin III made up a constant 46 +/- 8% (+/- SD) of the total immunoactive material, the remainder being composed of smaller metabolic fragments, indicating a rapid rate of clearance of angiotensin III. Captopril completely inhibited the rise in angiotensin III after des-Asp1-[Ile5]angiotensin I infusion. A substance which chromatographed as des-Asp-[Ile5]angiotensin I was detected in rat blood and made up 19% of the angiotensin I immunoactive material, while angiotensin III made up 44% of the angiotensin II immunoactive material. These results confirm that des-Asp1-[Ile5]angiotensin I is a substrate for converting enzyme in the rat, and the presence of a chromatographically similar substance in the circulation suggests that at least part of the angiotensin III in rat blood may be formed by the action of converting enzyme on endogenous des-Asp-angiotensin I. (Endocrinology 108: 406, 1981)





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1981 by The Endocrine Society